In case you missed it: March 8 to March 12


It was a very busy week for the Contemporary OB/GYN team.

This week’s top articles included:

How insurance impacts access to NIPT

Some women are unable to choose noninvasive prenatal testing (NIPT), due to lack of insurance coverage, according to a pilot study in the Journal of Community Genetics.

Cost of cell-free DNA noninvasive testing for Down syndrome

A small percentage of women whose noninvasive prenatal testing (NIPT) results were negative regretted taking the test and blamed themselves, according to a 1-year postpartum questionnaire survey.

Inclusion necessary in clinical trials

This month’s issue brings with it hope for a spring season that will see an easing of COVID-19 cases and deaths, despite new virus mutations.

Improvements in Research Needed for Reproductive Health of Transgender and Gender Diverse People

The scoping review revealed target areas that require additional research, as well as a need for more variety in study designs, populations, and locations.

Related Videos
Fezolinetant effective against vasomotor symptoms | Image Credit:
Discussing PCOS: misconceptions, management, encouragement | Image Credit:
The importance of diversity in obstetrics | Image Credit: ©
Study confirms efficacy of JADA against postpartum bleeding | Image Credit: © Amy Taneja MD - © Amy Taneja MD -
Matthew Zerden, MD
John Stanley, MD
Marci Bowers, MD | Image Credit:
Related Content
© 2023 MJH Life Sciences

All rights reserved.